What sizes are available for Leukemia inhibitory factor LIF Rabbit Polyclonal Antibody?

Leukemia inhibitory factor LIF Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Leukemia inhibitory factor LIF Rabbit Polyclonal Antibody

Q: What is the catalog number for Leukemia inhibitory factor LIF Rabbit Polyclonal Antibody?

The catalog number for Leukemia inhibitory factor LIF Rabbit Polyclonal Antibody is orb48028.

Anti-Leukemia inhibitory factor LIF Antibody. Tested in WB applications. This antibody reacts with Mouse, Rat.

Product Specifications

Product Name Alternative

Leukemia inhibitory factor; LIF; Differentiation-stimulating factor; D factor; Lif

UniProt

P09056

Reactivity

Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of mouse LIF, identical to the related rat sequence.

Target

Leukemia inhibitory factor

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cancer Biology; Immunology & Inflammation, Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Neuroscience, Stem Cell & Developmental Biology

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Mouse, Rat

Form

Lyophilized

Molecular Weight

40 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.